MedPath

IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact

Not Applicable
Recruiting
Conditions
Atherosclerosis
Interventions
Device: Eagle Eye Platinum digital IVUS catheter with optional SyncVision
Device: Resolute Onyx Drug Eluting Stent
Device: Onyx Frontier Drug Eluting Stent
Device: Onyx TruStar Drug Eluting Stent
Device: Onyx TruCor Drug Eluting Stent
Registration Number
NCT04221815
Lead Sponsor
Medstar Health Research Institute
Brief Summary

Intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) has been shown in clinical trials, registries, and meta-analyses to reduce recurrent events after PCI. This is accomplished by improving the angiographic result with lesion and vessel assessment to guide stent selection and implantation and intravascular imaging following stent implantation to ensure an adequate treatment endpoint has been achieved. Despite extensive literature supporting the use of IVUS in PCI, utilization remains low in the United States. An increasing number of high-risk or complex lesions are being treated with PCI and we hypothesize that the impact of IVUS in these complex lesions will be of increased importance in reducing clinical adverse events while remaining cost effective.

Detailed Description

This is a prospective, single-blind clinical investigation randomizing subjects to IVUS-guided coronary stent implantation vs. angiography-guided coronary stent implantation in a 1:1 ratio.

The clinical investigation will be conducted at approximately 120 centers in the US, Canada, and Europe. Approximately 2,500-3,100 randomized subjects and up to 3 roll-in subjects per site will be enrolled in this study. Subjects participating in this clinical investigation will be followed for 2 years. The expected duration of enrollment is approximately 2.5 years. The total duration of the clinical investigation is expected to be approximately 4.5 years.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
3100
Inclusion Criteria
  • Age ≥ 18 years at screening
  • PCI with stent implantation involving a high risk or complex lesion defined as involving at least one of the following characteristics:
  • Chronic total occlusion
  • In-stent restenosis
  • Severe coronary artery calcification
  • Long lesion (≥ 28 mm in length)
  • Bifurcation lesion (Any Medina class that involves main branch disease with a side branch ≥2.0 mm)
  • Stable angina, unstable angina, or non-ST Elevation myocardial infarction (NSTEMI), undergoing PCI of a single or multivessel coronary artery stenosis
  • PCI performed with either angiography alone, or IVUS guidance used
Exclusion Criteria
  • Subjects with acute ST elevation myocardial infarction (STEMI), or cardiogenic shock
  • Use of fibrinolytic therapy within 24 hours of PCI
  • Planned revascularization of a target vessel as a staged procedure
  • Stent thrombosis
  • Use of optical coherence tomography (OCT) during the index procedure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
IVUS guided PCIOnyx TruCor Drug Eluting StentPatients will receive a pre-PCI IVUS, IVUS guided stent sizing and optimization per study protocol, post-PCI IVUS
IVUS guided PCIResolute Onyx Drug Eluting StentPatients will receive a pre-PCI IVUS, IVUS guided stent sizing and optimization per study protocol, post-PCI IVUS
IVUS guided PCIOnyx Frontier Drug Eluting StentPatients will receive a pre-PCI IVUS, IVUS guided stent sizing and optimization per study protocol, post-PCI IVUS
Angiographic-guided PCIOnyx TruStar Drug Eluting StentPatients will receive angiography guided PCI and angiographic optimization per local standard practice, as well as a post-PCI IVUS blinded to the investigator
IVUS guided PCIEagle Eye Platinum digital IVUS catheter with optional SyncVisionPatients will receive a pre-PCI IVUS, IVUS guided stent sizing and optimization per study protocol, post-PCI IVUS
Angiographic-guided PCIOnyx TruCor Drug Eluting StentPatients will receive angiography guided PCI and angiographic optimization per local standard practice, as well as a post-PCI IVUS blinded to the investigator
IVUS guided PCIOnyx TruStar Drug Eluting StentPatients will receive a pre-PCI IVUS, IVUS guided stent sizing and optimization per study protocol, post-PCI IVUS
Angiographic-guided PCIResolute Onyx Drug Eluting StentPatients will receive angiography guided PCI and angiographic optimization per local standard practice, as well as a post-PCI IVUS blinded to the investigator
Angiographic-guided PCIOnyx Frontier Drug Eluting StentPatients will receive angiography guided PCI and angiographic optimization per local standard practice, as well as a post-PCI IVUS blinded to the investigator
Primary Outcome Measures
NameTimeMethod
IVUS core lab measures final PCI Minimum Stent AreaIntra-procedural

The imaging primary endpoint is the final post-PCI minimum stent area (MSA) assessed by IVUS in each randomized arm, measured at an independent IVUS core laboratory blinded to treatment assignment. The MSA is an appropriate co-primary imaging endpoint as it is the most consistent and strongest parameter to predict clinical outcomes.11-14 In the present study, after 2,000 subjects are enrolled with the procedure completed, the primary endpoint of MSA will be tested to compare the IVUS-guided and angiography-guided arms. If significantly larger MSA in the IVUS-guided arm is demonstrated, the trial will continue enrolling subjects.

Target vessel failure (TVF) outcomes at 12 months defined as the composite of cardiac death, target vessel related-myocardial infarction (MI), and ischemia-driven target vessel revascularization.12 months

The clinical primary endpoint is target vessel failure (TVF) outcomes at 12 months defined as the composite of cardiac death, target vessel related- myocardial infarction (MI), and target vessel revascularization.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (61)

Good Samaritan University Hospital

🇺🇸

West Islip, New York, United States

Thriassion General Hospital

🇬🇷

Magoúla, Greece

University of California San Deigo

🇺🇸

La Jolla, California, United States

Sahlgrenska University Hospital

🇸🇪

Gothenburg, Sweden

Rheinland Klinikum

🇩🇪

Neuss, Germany

University Hospital Careggi

🇮🇹

Florence, Italy

St. Vinzenz Hospital

🇩🇪

Cologne, North Rhine Westphalia, Germany

Northwell Health - South Shore University Hospital

🇺🇸

Bay Shore, New York, United States

University Medical Center Hamburg-Eppendorf

🇩🇪

Hamburg, Germany

SUNY Upstate Medical Center

🇺🇸

Syracuse, New York, United States

Helios Amper-Klinikum Dachau

🇩🇪

Dachau, Germany

University of North Carolina Rex Hospital

🇺🇸

Raleigh, North Carolina, United States

St. Francis

🇺🇸

Roslyn, New York, United States

Lehigh Valley Hospital

🇺🇸

Allentown, Pennsylvania, United States

AtlantiCare Regional Medical Center

🇺🇸

Pomona, New Jersey, United States

NYU Langone Hospital

🇺🇸

Brooklyn, New York, United States

Seton Medical Center Austin

🇺🇸

Austin, Texas, United States

Northwell Health - North Shore University Hospital

🇺🇸

Manhasset, New York, United States

DRK Kliniken Berlin Köpenik

🇩🇪

Berlin, Germany

Meir Medical Center

🇮🇱

Kfar Saba, Israel

Skane University Hospital

🇸🇪

Lund, Sweden

Northwell Health - Lennox Hill Hospital

🇺🇸

New York, New York, United States

Herz-und Diabeteszentrum NRW

🇩🇪

Bad Oeynhausen, NRW, Germany

General Hospital of Athens Hippokration

🇬🇷

Athens, Greece

Texas Tech University Health Sciences Center

🇺🇸

El Paso, Texas, United States

Segerberger Kliniken

🇩🇪

Bad Segeberg, Germany

Shamir Medical Center

🇮🇱

Be'er Ya'aqov, Israel

University of Messina

🇮🇹

Messina, Italy

Danderyd University Hospital

🇸🇪

Stockholm, Sweden

The Ohio State University Medical Center

🇺🇸

Columbus, Ohio, United States

Ascension Sacred Heart

🇺🇸

Pensacola, Florida, United States

Rush University Medial Center

🇺🇸

Chicago, Illinois, United States

Emory

🇺🇸

Atlanta, Georgia, United States

AdventHealth Sebring

🇺🇸

Sebring, Florida, United States

Northwest Medical Center

🇺🇸

Tucson, Arizona, United States

Central Arkansas Veterans Healthcare System

🇺🇸

Little Rock, Arkansas, United States

San Antonio Regional Hospital

🇺🇸

Upland, California, United States

Medstar Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

Manatee Memorial Hospital

🇺🇸

Bradenton, Florida, United States

Atlanta VA Medical Center

🇺🇸

Decatur, Georgia, United States

Northeast Georgia Medical Center

🇺🇸

Gainesville, Georgia, United States

Riverside Medical Center

🇺🇸

Kankakee, Illinois, United States

MercyOne Iowa Heart Center

🇺🇸

Des Moines, Iowa, United States

Carle Foundation Hospital

🇺🇸

Urbana, Illinois, United States

MedStar Southern Maryland Hospital Center

🇺🇸

Clinton, Maryland, United States

MedStar Union Memorial Hospital

🇺🇸

Baltimore, Maryland, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

Brigham and Women's Hospital

🇺🇸

Boston, Massachusetts, United States

Baystate Medical Center

🇺🇸

Springfield, Massachusetts, United States

Ascension St. John

🇺🇸

Dearborn, Michigan, United States

St. Luke's Hospital of Duluth

🇺🇸

Duluth, Minnesota, United States

Virtua Our Lady of Lourdes Hospital

🇺🇸

Camden, New Jersey, United States

Freeman Hospital

🇬🇧

Newcastle Upon Tyne, Tyne And Wear, United Kingdom

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

San Francisco VA Health Care System

🇺🇸

San Francisco, California, United States

Leeds General Infirmary

🇬🇧

Leeds, West Yorkshire, United Kingdom

University Medicine Rostock

🇩🇪

Rostock, Germany

Tampa Cardiovascular/St. Joseph's Hospital

🇺🇸

Tampa, Florida, United States

AdventHealth Orlando

🇺🇸

Orlando, Florida, United States

Carilion Clinic

🇺🇸

Roanoke, Virginia, United States

Imperial College Healthcare

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath